Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy

November 25, 2020
barry

previous post: Regulatory T cells engineered with TCR signaling–responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter
next post: A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant